No products
View larger ATP2020L
1000 Items
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $108.80 | Total: $544.00 |
| 1 | 10 | $92.16 | Total: $921.60 |
| 1 | 25 | $78.08 | Total: $1,952.00 |
| 1 | 50 | $66.56 | Total: $3,328.00 |
| 1 | 100 | $57.60 | Total: $5,760.00 |
| Molecular Formula | C227H346N62O66S |
| Molecular Weight | 5028.53 |
| Storage Condition | 0C Short Term, -20C Long Term |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CC[C@@H]([C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H]1CCCN1C([C@@H](NC([C@@H](N)CC2=CC=C(O)C=C2)=O)C)=O)=O)=O)[C@H](O)C)=O)CC3=CC=CC=C3)=O)[C@H](CC)C)=O)CO)=O)CC(O)=O)=O)CC4=CC=C(O)C=C4)=O)CO)=O)[C@H](CC)C)=O)C)=O)CCSC)=O)CC(O)=O)=O)CCCCN)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)CCC(N)=O)=O)[C@H](O)C)=O)[C@H](CC)C)=O)CC(N)=O)=O)CC5=CNC=N5)=O)CCCCN)=O)CC6=CNC7=CC=CC=C76)=O)CC(O)=O)=O)CO)=O)CCCCN)=O)CCCCN)=O)=O)CCCNC(N)=N)=O)CCC(N)=O)=O)C)=O)CC(C)C)=O)CC(C)C)=O)CC8=CNC9=CC=CC=C98)=O)CC(N)=O)=O)C(C)C)=O)CC%10=CC=CC=C%10)=O)CC(O)=O)=O)CCC(N)=O)=O)CCC(N)=O)=O)CCCNC(N)=N)=O)C.CC(O)=O |
| References | Irwin N, et al. Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist [Pro3]GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in obob mice. Diabetologia. 2007 Jul;50[7] 1532-40. |